{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:15:29Z","timestamp":1715984129826},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T00:00:00Z","timestamp":1111449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> The US West Nile virus (WNV) epidemic in the summer and fall of 2002 included the first documented cases of transfusion\u2010transmitted WNV infection. In December 2002, the FDA supported a voluntary market withdrawal by the blood banking community of frozen blood components collected in WNV high\u2010activity areas. At the time, the prevalence of viremia and serologic markers for WNV in the blood supply was undefined.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> In collaboration with America's Blood Centers, 1468 frozen plasma components (of approx. 60,000 frozen units voluntarily withdrawn from the market) were selectively retrieved from the peak epidemic regions and season (June 23, 2002\u2010September 28, 2002). These units were unlinked, subaliquoted, and tested by WNV enzyme immunoassays (EIAs; Focus Technologies and Abbott Laboratories) and nucleic acid amplification tests (NATs; Gen\u2010Probe Inc. and Roche Molecular Systems).<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Of the 1468 EIA results from Abbott and Focus, 7 were anti\u2010immunoglobulin M (IgM)\u2010 and anti\u2010immunoglobulin G (IgG)\u2010reactive by both assays, 8 and 1 were IgM\u2010only\u2010reactive, and 8 and 23 were IgG\u2010only\u2010reactive, respectively. NAT by Gen\u2010Probe and Roche Molecular Systems yielded one RNA\u2010positive, antibody\u2010negative unit containing approximately 440 RNA copies per mL. An additional 10\u2010fold replicate NAT testing by Gen\u2010Probe on 14 of 15 IgM\u2010reactive specimens yielded 2 additional IgM\u2010 and IgG\u2010reactive units with low\u2010level viremia (i.e., 7\/10 and 2\/10 replicates tested reactive).<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> The prevalence of acute (RNA\u2010positive) and recent (IgM\u2010seroreactive) WNV infections indicates that transfusion risk in high\u2010risk areas could have been considerable and that voluntary market withdrawal of frozen components likely averted some WNV transfusion transmissions. The existence of very\u2010low\u2010level viremic units raises concerns, because WNV minipool NAT screening will miss such units and individual NAT may not completely correct this situation.<\/jats:p>","DOI":"10.1111\/j.0041-1132.2005.04266.x","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T16:59:56Z","timestamp":1111510796000},"page":"480-486","source":"Crossref","is-referenced-by-count":13,"title":["Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic"],"prefix":"10.1111","volume":"45","author":[{"given":"L.H.","family":"Tobler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.B.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.","family":"Dille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.E.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.S.","family":"Lanciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Linnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gallarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Shyamala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,3,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0505.990506"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106143442401"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59403-8_11"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030969"},{"key":"e_1_2_6_6_2","volume-title":"FDA News: Statement on blood industry's voluntary market withdrawal of certain frozen blood products to reduce risk of west nile virus transmission from transfusion [Internet]. Rockville (MD):","year":"2002"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00501.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038138"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.1.12-15.2004"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.9.4040-4047.2001"},{"key":"e_1_2_6_11_2","first-page":"764","article-title":"Detection of West Nile virus (WNV)\u2010specific immunoglobulin M in a reference laboratory setting during the 2002 WNV season in the United States","volume":"10","author":"Prince HE","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/381461"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.7.2408-2419.2002"},{"key":"e_1_2_6_14_2","unstructured":"KacianDL FulzTJ.Nucleic acid sequence amplification methods.US patent 5 399 491.1995."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/35.8.1588"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/26.9.2224"},{"key":"e_1_2_6_17_2","first-page":"797","volume-title":"Diagnostic procedures for viral, rickettsial and chlamydial infections","author":"Beaty BJ","year":"1989"},{"key":"e_1_2_6_18_2","unstructured":"CagliotiS McAuleyJ RobertsonGF et al.Relative yield of mini\u2010pool versus individual donation NAT for West Nile virus RNA [abstract]. Transfusion2004;44(Suppl):6A."},{"key":"e_1_2_6_19_2","first-page":"281","article-title":"Update: West Nile virus screening of blood donations and transfusion\u2010associated transmission\u2014United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention (CDC).","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04227.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0041-1132.2005.04266.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0041-1132.2005.04266.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:45:59Z","timestamp":1697258759000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0041-1132.2005.04266.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,22]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.0041-1132.2005.04266.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0041-1132.2005.04266.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,22]]}}}